8-K
false000090312900009031292024-02-212024-02-21

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 21, 2024

 

 

GENTHERM INCORPORATED

(Exact name of Registrant as Specified in Its Charter)

 

 

Michigan

0-21810

95-4318554

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

21680 Haggerty Road

 

Northville, Michigan

 

48167

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (248) 504-0500

 

N/A

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Common Stock, no par value

 

THRM

 

The Nasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 


Item 2.02 Results of Operations and Financial Condition.

On February 21, 2024, Gentherm Incorporated (the “Company”) publicly announced its financial results for the fourth quarter and full year for 2023, and provided 2024 guidance and a revised 2026 outlook. A copy of the Company’s news release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

On February 21, 2024 at 8:00 a.m. Eastern Time, the Company will host an enhanced earnings conference call and webcast to discuss the fourth quarter and full year 2023 financial results, 2024 guidance and a revised 2026 outlook. A copy of certain of the supplemental materials that will be used during the conference call is attached hereto as Exhibit 99.2 and is incorporated herein by reference.

The information in Items 2.02 and 7.01 herein and the attached exhibits 99.1 and 99.2 shall not be deemed filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly stated by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit 99.1

Company news release dated February 21, 2024 concerning financial results, guidance and outlook

Exhibit 99.2

Supplemental materials dated February 21, 2024

Exhibit 104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

GENTHERM INCORPORATED

 

 

 

 

By:

 

/s/ Wayne Kauffman

 

 

 

Wayne Kauffman

 

 

 

Senior Vice President, General Counsel and Secretary

Date: February 21, 2024

 

 

 

 


EX-99.1

 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

Exhibit 99.1

Gentherm Reports 2023 Fourth Quarter and Full Year Results

Achieves Record Annual Revenue of $1.5 Billion

Secures Unprecedented Annual Automotive Business Awards of $2.6 Billion

Establishes 2024 Guidance and Updates 2026 Outlook

NORTHVILLE, Michigan, February 21, 2024 /Global Newswire/ -- Gentherm (NASDAQ:THRM), the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems, today announced its financial results for the fourth quarter and full year ended December 31, 2023.

Fourth Quarter 2023 Highlights

Product revenues of $366.9 million increased 6.9% from $343.3 million in the 2022 fourth quarter. Excluding the impact of foreign currency translation, product revenues increased 5.2% year over year
Automotive revenues increased 6.6% year over year; excluding the impact of foreign currency translation, increased 4.9% year over year
GAAP diluted earnings per share was $0.56 as compared with loss per share of $(0.13) for the prior year period
Adjusted diluted earnings per share (see table herein) was $0.90. Adjusted diluted earnings per share in the prior year period was $0.47
Secured new automotive business awards totaling approximately $900 million
Repurchased $61.4 million of the Company’s common stock

Full Year 2023 Highlights

Product revenues of $1,469.1 million increased 21.9% from $1,204.7 million in 2022. Excluding the impact of foreign currency translation and contributions from acquisitions, product revenues increased 10.0% year over year
Automotive revenues increased 22.5% year over year; excluding the impact of foreign currency translation and contributions from the Alfmeier acquisition, automotive revenues increased 10.4% year over year
GAAP diluted earnings per share was $1.22 as compared with $0.73 for the prior year period
Adjusted diluted earnings per share (see table herein) was $2.59. Adjusted diluted earnings per share in the prior year was $1.82
Secured new automotive business awards totaling $2.6 billion
Repurchased $92.5 million of the Company’s common stock

“Our financial results for 2023 reflect the continued strong execution by the global Gentherm team, enabling us to deliver record annual revenue in both Automotive and Medical as well as record adjusted EBITDA. In addition, we secured an unprecedented $2.6 billion dollars in new automotive awards. Of note, we won a breakthrough scalable ClimateSense® software award for nearly all future architecture General Motors ICE and electric vehicles. Our climate and comfort wins across the globe demonstrate our clear industry leading position. In addition, we have effectively leveraged the Alfmeier acquisition and won conquest pneumatic lumbar and massage awards with a growing number of OEMs, securing our position as the global leader, said Phil Eyler, Gentherm’s President and Chief Executive Officer.

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

Eyler continued, “We continue to lead the industry with differentiated, proprietary technologies such as ClimateSense® and WellSenseTM. We were excited to unveil WellSenseTM at the Consumer Electronics Show in January. This software defined consumer experience delivers customized in-cabin wellness, alertness and well-being sensations. These proprietary innovations are expected to significantly increase Gentherm’s content per vehicle and position us to be a strong contributor to software defined vehicles of the future.

He concluded: “We remained disciplined in managing operating expenses and are making good progress on our Fit-for-Growth 2.0 initiatives as well as our footprint expansion in Tangier, Morocco and Monterrey, Mexico. With these actions, we continue to build momentum on our margin expansion.”

2023 Fourth Quarter Financial Review

Product revenues of $366.9 million increased $23.6 million, or 6.9%, in the fourth quarter of 2023 compared with the prior year period. Excluding the impact of foreign currency translation, product revenues increased 5.2% year over year.

Automotive revenue increased 6.6% year over year with revenue increases in all product categories except Electronics and Other Automotive. Adjusting for foreign currency translation, Automotive revenue increased 4.9% year over year. Excluding the impact from the UAW strike, phasing out the non-automotive electronics business as well as one-time benefits from recoveries in both periods, Automotive revenue increased 10.1% year over year. According to S&P Global’s mid-February 2024 report, actual light vehicle production in the fourth quarter of 2023 increased by 12.8% compared to the fourth quarter of 2022 in the Company’s key markets of North America, Europe, China, Japan and Korea.

Gentherm Medical revenue increased 15.2% year over year, or 13.1% excluding the impact of foreign currency translation, primarily as a result of higher Blanketrol® sales.

See the “Revenues by Product Category” table included below for additional detail.

Gross margin rate was 26.2% in the current year period versus 20.3% in the prior year period, primarily as a result of lower freight costs, fixed cost leverage from higher unit volume, increased productivity at the manufacturing facilities and supplier cost reductions, as well as the impairment charge related to the exit of the non-automotive electronics business in the prior year period. These were partially offset by wage inflation and lower price recoveries.

Net research and development expenses of $21.4 million in the 2023 fourth quarter decreased $1.9 million, or 8.3% over the prior year period, primarily as a result of higher reimbursement for design and development costs.

Selling, general and administrative expenses of $41.9 million in the 2023 fourth quarter increased $5.3 million, or 14.5%, versus the prior year period. The year-over-year increase was primarily driven by higher incentive compensation.

Acquisition and integration expenses of $0.6 million in the current year period were $3.7 million lower than the prior year period as a result of fewer expenses associated with the Alfmeier and Dacheng acquisitions. Restructuring expenses were $1.3 million in the current year period.

As described more fully in the “Reconciliation of Net Income (Loss) to Adjusted EBITDA” table included below, the Company recorded Adjusted EBITDA of $49.0 million in the 2023 fourth quarter compared with $40.9 million in the prior year period, an increase of $8.1 million or 19.7%.

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

Income tax benefit in the 2023 fourth quarter was $0.9 million, as compared with $0.06 million in the prior year period.

GAAP diluted earnings per share for the fourth quarter of 2023 was $0.56 compared with a loss of $(0.13) for the prior year period. Adjusted diluted earnings per share, excluding unrealized currency loss, non-cash purchasing accounting impact, restructuring expenses, acquisition and integration expenses, and other impacts (see table herein), was $0.90. Adjusted diluted earnings per share in the prior year period was $0.47.

2023 Full Year Financial Review

For full year 2023, the Company reported product revenues of $1,469.1 million, a 21.9% increase over the prior year. Excluding the impact of foreign currency translation and contributions from acquisitions, product revenues increased 10.0% year over year.

In the Automotive segment, 2023 full-year revenue was $1,423.0 million, a 22.5% increase compared to the prior year. Revenue increased in all product categories except Electronics and Other Automotive. Adjusting for foreign currency translation and the impact of the Alfmeier acquisition, organic Automotive revenue increased 10.4% year over year. Excluding the impact from the UAW strike, phasing out the non-automotive electronics business as well as one-time benefits from recoveries in both years, organic Automotive revenue increased 13.4% year over year. According to IHS Markit's mid-February 2024 report for full-year 2023, actual light vehicle production increased 11.4% compared to full year 2022 in the Company’s key markets of North America, Europe, China, Japan and Korea.

The Medical segment revenue was $46.1 million for full year 2023, a 7.2% increase compared to the prior year. Adjusting for foreign currency translation, Medical revenues increased 6.9%, primarily as a result of increased revenues from its Dacheng air warming blankets.

Gross margin rate was 23.9% in 2023, a 120 basis point increase from 2022, primarily as a result of fixed cost leverage from higher unit volume, lower freight costs, increased productivity at the manufacturing facilities, as well as the impairment charge related to the exit of the non-automotive electronics business in the prior year period. These were partially offset by wage inflation.

Net research and development expenses of $94.4 million in 2023 increased 10.1% primarily as a result of the additional expenses from the Alfmeier business as well as increased investments to support new automotive business awards.

Selling, general and administrative expenses of $155.6 million in 2023 increased $22.9 million, or 17.2%, versus the prior year period. The year over year increase was primarily driven by additional expenses from acquired businesses and higher compensation expenses, partially offset by lower acquisition expenses.

Acquisition and integration expenses of $5.3 million in 2023 were $17.3 million lower than the prior year as a result of expenses associated with the Alfmeier and Dacheng acquisitions and realized foreign currency loss in the prior year. The Company incurred $4.7 million restructuring expenses in 2023, compared to $0.6 million in the prior year period. The Company recorded impairment of goodwill charges of $19.5 million for the year.

As described more fully in the “Reconciliation of Net Income (Loss) to Adjusted EBITDA” table included below, the Company recorded Adjusted EBITDA of $180.6 million in 2023 compared with $137.2 million in the prior year, an increase of $43.4 million or 31.6%.

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

Income tax expense in 2023 was $14.6 million, as compared with $13.9 million in the prior year. The effective tax rate was 26.6% for 2023. This rate differed from the Federal statutory rate of 21%, primarily due to unfavorable geographic mix of earnings as well as the impact of the goodwill impairment recorded in the second quarter.

GAAP diluted earnings per share for full year 2023 was $1.22, as compared with $0.73 for the prior year. Adjusted diluted earnings per share, excluding impairment of goodwill, unrealized currency loss, non-cash purchasing accounting impact, non-automotive electronics inventory charge and other impacts (see table herein), was $2.59. Adjusted diluted earnings per share in the prior year were $1.82.

Guidance

The Company is providing the following guidance for full year 2024:

Product revenues between $1.5 billion and $1.6 billion, based on the current forecast of customer orders, light vehicle production in the Company’s key markets declining at a low single digit rate, and a EUR to USD exchange rate of $1.10/Euro
Adjusted EBITDA between 12.5% and 13.5% of product revenues
Full year effective tax rate between 26% and 29%
Capital expenditures between $65 million and $75 million

As a result of the Company’s decision to pause the pursuit of certain Battery Performance Solutions products, Gentherm is updating its 2026 outlook:

Product Revenues between $1.9 billion and $2.0 billion
Adjusted EBITDA margin rate of approximately 16%

Webcast and Conference Call

As previously announced, Gentherm will conduct a live audio webcast with a presentation at 8:00 AM Eastern Time to review these results. The live webcast and one-year archived replay of the call can be accessed on the Events page of the Investor section of Gentherm's website at www.gentherm.com.

The dial-in number for the call is 1-877-407-4018 (callers in the U.S.) or +1-201-689-8471 (callers outside this U.S.). The passcode for the live call is 13744168.

A telephonic replay will be available approximately two hours after the call until 11:59 PM Eastern Time on March 6, 2024. The replay can be accessed by dialing 1-844-512-2921 (callers in the U.S.), or +1-412-317-6671 (callers outside the U.S.). The passcode for the replay is 13744168.

Investor Relations Contact
Yijing Brentano

investors@gentherm.com
248.308.1702

Media Contact

Melissa Fischer

media@gentherm.com

248.289.9702

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

About Gentherm

Gentherm (NASDAQ: THRM) is the global market leader of innovative thermal management and pneumatic comfort technologies for the automotive industry and a leader in medical patient temperature management systems. Automotive products include variable temperature Climate Control Seats, heated automotive interior systems (including heated seats, steering wheels, armrests and other components), battery performance solutions, cable systems, lumbar and massage comfort solutions, valve system technologies, and other electronic devices. Medical products include patient temperature management systems. The Company is also developing a number of new technologies and products that will help enable improvements to existing products and to create new product applications for existing and new markets. Gentherm has more than 14,000 employees in facilities in the United States, Germany, China, Czech Republic, Hungary, Japan, Malta, Mexico, North Macedonia, South Korea, United Kingdom, Ukraine, and Vietnam. For more information, go to www.gentherm.com.

 

Forward Looking Statements

Except for historical information contained herein, statements in this release are forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward looking statements represent Gentherm Incorporated's goals, beliefs, plans and expectations about its prospects for the future and other future events. The forward-looking statements included in this release are made as of the date hereof or as of the date specified herein and are based on management's reasonable expectations and beliefs. Such statements are subject to a number of important assumptions, significant risks and uncertainties (some of which are beyond our control) and other factors that may cause actual results or performance to differ materially from that described in or indicated by the forward looking statements, including but not limited to:

 

macroeconomic, geopolitical and similar global factors in the cyclical Automotive industry;
increasing U.S. and global competition, including with non-traditional entrants;
our ability to effectively manage new product launches and research and development, and the market acceptance of such products and technologies;
the evolution and recent challenges of the automotive industry towards electric vehicles, autonomous vehicles and mobility on demand services, and related consumer behaviors and preferences;
our ability to convert new business awards into product revenues;
the ongoing supply constrained environment, and inflationary and other cost pressures;
the production levels of our major customers and OEMs in our key markets and sudden fluctuations in such production levels;
our ability to attract and retain highly skilled employees and wage inflation;
a tightening labor market, labor shortages or work stoppages impacting us, our customers or our suppliers, including labor strikes among certain OEMs and suppliers;
our achievement of product cost reductions to offset customer imposed price reductions or other pricing pressures;
our ability to integrate our recent acquisitions, as well as to consummate additional strategic acquisitions, investments and exits, and achieve planned benefits;
any security breaches and other disruptions to our information technology networks and systems, as well as privacy, data security and data protection risks;
the impact of our global operations, including our global supply chain, operations within Ukraine, economic and trade policies, and foreign currency and exchange risk;

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

any loss or insolvency of our key customers and OEMs, or key suppliers;
our efforts to optimize our global supply chain and manufacturing footprint;
our ability to project future sales volume based on third-party information, based on which we manage our business;
the protection of our intellectual property in certain jurisdictions;
our compliance with anti-corruption laws and regulations;
legal and regulatory proceedings and claims involving us or one of our major customers;
the extensive regulation of our patient temperature management business;
risks associated with our manufacturing processes;
the effects of climate change and catastrophic events, as well as regulatory and stakeholder-imposed requirements and expectations to address climate change and other sustainability issues;
our product quality and safety;
our borrowing availability under our revolving credit facility, as well as our ability to access the capital markets, to support our planned growth; and
our indebtedness and compliance with our debt covenants.

The foregoing risks should be read in conjunction with the Company's reports filed with or furnished to the Securities and Exchange Commission (the “SEC”), including “Risk Factors,” in its most recent Annual Report on Form 10-K and subsequent SEC filings, for a discussion of these and other risks and uncertainties. In addition, with reasonable frequency, we have entered into business combinations, acquisitions, divestitures, strategic investments and other significant transactions. Such forward-looking statements do not include the potential impact of any such transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results.

Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

 

 

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF INCOME (LOSS)

(In thousands, except per share data)

(Unaudited)

 

 

 

Three Months Ended
December 31,

 

 

Year Ended
December 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Product revenues

 

$

366,933

 

 

$

343,322

 

 

$

1,469,076

 

 

$

1,204,656

 

Cost of sales

 

 

270,637

 

 

 

273,514

 

 

 

1,117,452

 

 

 

931,006

 

Gross margin

 

 

96,296

 

 

 

69,808

 

 

 

351,624

 

 

 

273,650

 

Operating expenses:

 

 

 

 

 

 

 

 

 

 

 

 

Net research and development expenses

 

 

21,367

 

 

 

23,297

 

 

 

94,358

 

 

 

85,722

 

Selling, general and administrative expenses

 

 

41,899

 

 

 

36,584

 

 

 

155,579

 

 

 

132,693

 

Impairment of goodwill

 

 

 

 

 

 

 

 

19,509

 

 

 

 

Restructuring expenses

 

 

1,327

 

 

 

76

 

 

 

4,739

 

 

 

637

 

Impairment of intangible assets and property and equipment

 

 

 

 

 

6,291

 

 

 

 

 

 

6,291

 

Total operating expenses

 

 

64,593

 

 

 

66,248

 

 

 

274,185

 

 

 

225,343

 

Operating income

 

 

31,703

 

 

 

3,560

 

 

 

77,439

 

 

 

48,307

 

Interest expense, net

 

 

(5,197

)

 

 

(3,009

)

 

 

(14,641

)

 

 

(4,294

)

Foreign currency loss

 

 

(6,302

)

 

 

(5,262

)

 

 

(5,918

)

 

 

(6,778

)

Other (loss) income

 

 

(2,984

)

 

 

449

 

 

 

(1,926

)

 

 

1,147

 

Earnings (loss) before income tax

 

 

17,220

 

 

 

(4,262

)

 

 

54,954

 

 

 

38,382

 

Income tax (gain) expense

 

 

(867

)

 

 

(57

)

 

 

14,611

 

 

 

13,941

 

Net income (loss)

 

$

18,087

 

 

$

(4,205

)

 

$

40,343

 

 

$

24,441

 

Basic earnings (loss) per share

 

$

0.57

 

 

$

(0.13

)

 

$

1.23

 

 

$

0.74

 

Diluted earnings (loss) per share

 

$

0.56

 

 

$

(0.13

)

 

$

1.22

 

 

$

0.73

 

Weighted average number of shares – basic

 

 

31,974

 

 

 

33,186

 

 

 

32,778

 

 

 

33,126

 

Weighted average number of shares – diluted

 

 

32,200

 

 

 

33,186

 

 

 

33,067

 

 

 

33,503

 

 

 

 

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

GENTHERM INCORPORATED

REVENUE BY PRODUCT CATEGORY AND RECONCILIATION OF FOREIGN CURRENCY TRANSLATION IMPACT

(In thousands)

(Unaudited)

 

 

 

Three Months Ended
December 31,

 

 

Year Ended
December 31,

 

 

 

2023

 

 

2022

 

% Change

 

 

2023

 

 

2022

 

% Change

 

Climate Control Seat

 

$

121,797

 

 

$

114,765

 

 

6.1

 %

 

$

482,665

 

 

$

426,046

 

 

13.3

 %

Seat Heaters

 

 

77,456

 

 

 

73,603

 

 

5.2

 %

 

 

308,588

 

 

 

283,970

 

 

8.7

 %

Steering Wheel Heaters

 

 

38,777

 

 

 

31,780

 

 

22.0

 %

 

 

153,943

 

 

 

120,949

 

 

27.3

 %

Lumbar and Massage Comfort Solutions (a)

 

 

35,321

 

 

 

34,240

 

 

3.2

 %

 

 

144,923

 

 

 

56,980

 

 

154.3

 %

Valve Systems (a)

 

 

23,746

 

 

 

23,438

 

 

1.3

 %

 

 

106,262

 

 

 

41,980

 

 

153.1

 %

Automotive Cables

 

 

19,862

 

 

 

17,300

 

 

14.8

 %

 

 

79,993

 

 

 

76,962

 

 

3.9

 %

Battery Performance Solutions

 

 

18,346

 

 

 

16,512

 

 

11.1

 %

 

 

75,484

 

 

 

71,907

 

 

5.0

 %

Electronics

 

 

9,931

 

 

 

10,916

 

 

(9.0

)%

 

 

40,387

 

 

 

44,106

 

 

(8.4

)%

Other Automotive

 

 

8,709

 

 

 

9,492

 

 

(8.2

)%

 

 

30,707

 

 

 

38,716

 

 

(20.7

)%

Subtotal Automotive segment

 

 

353,945

 

 

 

332,046

 

 

6.6

 %

 

 

1,422,952

 

 

 

1,161,616

 

 

22.5

 %

Medical segment (b)

 

 

12,988

 

 

 

11,276

 

 

15.2

 %

 

 

46,124

 

 

 

43,040

 

 

7.2

 %

Total Company

 

$

366,933

 

 

$

343,322

 

 

6.9

 %

 

$

1,469,076

 

 

$

1,204,656

 

 

21.9

 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Foreign currency translation impact (c)

 

 

5,841

 

 

 

 

 

 

 

 

879

 

 

 

 

 

 

Total Company, excluding foreign
currency translation impact

 

$

361,092

 

 

$

343,322

 

 

5.2

 %

 

$

1,468,197

 

 

$

1,204,656

 

 

21.9

 %

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Represents product revenues from Alfmeier since the acquisition date of August 1, 2022.

 

(b) Includes product revenues of $2,224 and $7,163 for the three and twelve months ended December 31, 2023, respectively, and $2,128 and $3,362 for the three and twelve months ended December 31, 2022, respectively, from Dacheng since the acquisition date of July 13, 2022.

 

(c) Foreign currency translation impacts for the Automotive segment and Medical segment were $5,603 and $238, respectively, for the three months ended December 31, 2023. Foreign currency translation impacts for the Automotive segment and Medical segment were $760 and $119, respectively, for the twelve months ended December 31, 2023. Foreign currency translation impacts for Alfmeier and Dacheng were $2,445 and $(106), respectively, for the twelve months ended December 31, 2023.

 

 

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

 

 

Three Months Ended December 31,

 

 

 

2023

 

 

2022

 

Automotive revenues

 

$

353,945

 

 

$

332,046

 

UAW strike impact

 

 

(9,319

)

 

 

 

Non-automotive electronics revenues

 

 

2,742

 

 

 

3,102

 

One-time customer recoveries

 

 

3,732

 

 

 

10,003

 

Adjusted Automotive revenues

 

 

356,790

 

 

 

318,941

 

Foreign currency translation impact

 

 

5,619

 

 

 

 

Adjusted Automotive revenues, excluding foreign currency translation impact

 

$

351,171

 

 

$

318,941

 

Year over Year % change

 

 

10.1

 %

 

 

 

 

 

 

 

 

 

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Automotive revenues

 

$

1,422,952

 

 

$

1,161,616

 

Lumbar and Massage Comfort Solutions

 

 

144,923

 

 

 

56,980

 

Valve Systems

 

 

106,262

 

 

 

41,980

 

Organic Automotive revenues

 

 

1,171,767

 

 

 

1,062,656

 

UAW strike impact

 

 

(9,001

)

 

 

 

Non-automotive electronics revenues

 

 

13,091

 

 

 

15,758

 

One-time customer recoveries

 

 

5,332

 

 

 

20,501

 

Adjusted organic Automotive revenues

 

 

1,162,345

 

 

 

1,026,397

 

Foreign currency translation impact

 

 

(1,369

)

 

 

 

Adjusted organic Automotive revenues, excluding foreign currency translation impact

 

$

1,163,714

 

 

$

1,026,397

 

Year over Year % change

 

 

13.4

 %

 

 

 

 

 

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

GENTHERM INCORPORATED

RECONCILIATION OF NET INCOME (LOSS) TO ADJUSTED EBITDA

(In thousands)

(Unaudited)

 

 

 

Three Months Ended
December 31,

 

 

Year Ended
December 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net income (loss)

 

$

18,087

 

 

$

(4,205

)

 

$

40,343

 

 

$

24,441

 

Add back:

 

 

 

 

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

12,062

 

 

 

13,779

 

 

 

50,416

 

 

 

44,038

 

Income tax (benefit) expense (a)

 

 

(867

)

 

 

(57

)

 

 

14,611

 

 

 

13,941

 

Interest expense, net (b)

 

 

5,197

 

 

 

3,009

 

 

 

14,641

 

 

 

4,294

 

Adjustments:

 

 

 

 

 

 

 

 

 

 

 

 

Non-cash stock-based compensation (c)

 

 

3,164

 

 

 

2,771

 

 

 

11,756

 

 

 

7,393

 

Restructuring expense

 

 

1,327

 

 

 

76

 

 

 

4,739

 

 

 

637

 

Unrealized currency loss

 

 

4,898

 

 

 

5,678

 

 

 

9,125

 

 

 

4,646

 

Acquisition and integration expenses

 

 

578

 

 

 

4,261

 

 

 

5,308

 

 

 

22,618

 

Impairment of goodwill

 

 

 

 

 

 

 

 

19,509

 

 

 

 

Non-automotive electronics inventory charge

 

 

575

 

 

 

 

 

 

6,064

 

 

 

 

Impairment of intangible assets and property and equipment

 

 

 

 

 

15,669

 

 

 

 

 

 

15,669

 

Other (d)

 

 

4,001

 

 

 

(32

)

 

 

4,072

 

 

 

(515

)

Adjusted EBITDA

 

$

49,022

 

 

$

40,949

 

 

$

180,584

 

 

$

137,162

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Product revenues

 

$

366,933

 

 

$

343,322

 

 

$

1,469,076

 

 

$

1,204,656

 

Adjusted EBITDA Margin

 

 

13.4

%

 

 

11.9

%

 

 

12.3

%

 

 

11.4

%

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Includes $2,423 of deferred income tax benefit associated with the goodwill impairment of the Medical Reporting Unit for the twelve months ended December 31, 2023.

 

(b) Includes $1,444 and $710 of interest expense for the three months and twelve months ended December 31, 2023, related to mark-to-market adjustment of our floating-to-fixed interest rate swap agreement with a notional amount of $100,000.

 

(c) Includes operating expenses of $3,164 and $2,763 for the three months ended December 31, 2023 and 2022, respectively. Includes operating expenses of $11,382 and $6,904 for the twelve months ended December 31, 2023 and 2022, respectively.

 

(d) Includes $2,900 of non-cash impairment charges related to our Carrar Ltd. Investment for the three and twelve months ended December 31, 2023.

 

 

 

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

Use of Non-GAAP Financial Measures

In addition to the results reported in accordance with GAAP throughout this release, the Company has provided here or elsewhere information regarding adjusted earnings before interest, taxes, depreciation and amortization (“Adjusted EBITDA”), Adjusted EBITDA margin, adjusted earnings per share (“Adjusted earnings per share” or “Adjusted EPS”), free cash flow, Net Debt, organic revenue, revenue (for the Company and by each reporting segment) excluding acquired businesses and foreign currency translation, revenue excluding foreign currency translation, Automotive revenue excluding the impact from the United Auto Workers strike, non-automotive electronics, one-time customer recoveries and foreign currency translation, organic Automotive revenue excluding the impact from the United Auto Workers strike, non-automotive electronics, one-time customer recoveries and foreign currency translation, adjusted operating expenses, pro forma product revenues, pro forma Adjusted EBITDA, pro forma Adjusted EBITDA margin and adjusted effective tax rate, each a non-GAAP financial measure. The Company defines Adjusted EBITDA as earnings before interest, taxes, depreciation and amortization, deferred financing cost amortization, non-cash stock-based compensation expenses, and other gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, impairment of goodwill, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. Note that in recent prior periods, the Company did not exclude non-cash stock-based compensation expenses in the definition of Adjusted EBITDA. Forward-looking references to Adjusted EBITDA and Adjusted EBITDA margin herein exclude the impact of stock-based compensation as newly defined. The Company defines Adjusted EBITDA margin as Adjusted EBITDA divided by product revenues. The Company defines Adjusted EPS as earnings adjusted by gains and losses not reflective of the Company’s ongoing operations and related tax effects including transaction expenses, debt retirement expenses, impairment of assets held for sale, impairment of goodwill, gain or loss on sale of business, restructuring expense, unrealized currency gain or loss and unrealized revaluation of derivatives. The Company defines Free Cash Flow as Net cash provided by operating activities less Purchases of property and equipment. The Company defines Net Debt as the principal amount of all Consolidated Funded Indebtedness (as defined in the Credit Agreement) less cash and cash equivalents. The Company defines organic revenue as revenue, excluding revenue from acquired businesses. Note that in recent prior periods, the Company used organic revenue instead to be revenue excluding foreign currency translation (see below). The Company defines revenue excluding acquired businesses and foreign currency translation as revenue, excluding the revenue from acquired businesses and the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates. The Company defines revenue excluding foreign currency translation as revenue, excluding the estimated effects of foreign currency exchange on revenue by translating actual revenue using the prior period foreign currency exchange rates. The Company defines Automotive revenue excluding the impact from the United Auto Workers strike, non-automotive electronics, one-time customer recoveries and foreign currency translation as Automotive revenue excluding the items specified. The Company defines organic Automotive revenue excluding the impact from the United Auto Workers strike, non-automotive electronics, one-time customer recoveries and foreign currency translation as organic revenues excluding the items specified. The Company defines adjusted operating expenses as operating expenses excluding impairment of intangible assets and property and equipment, restructuring, related non-cash stock-based compensation, acquisition, integration and divestiture expenses. The Company defines pro forma product revenues as product revenues including the product revenues of Alfmeier as if the acquisition had occurred as of January 1, 2022. The Company defines pro forma Adjusted EBITDA as Adjusted EBITDA, as defined above, including the results of Alfmeier as if the acquisition had occurred as of January 1, 2022. The Company defines pro forma Adjusted EBITDA margin as pro forma Adjusted EBITDA, as defined above, divided by pro forma product revenues. The Company defines adjusted effective tax rate as income tax expense excluding the tax benefit from non-cash goodwill impairment divided by earnings before income tax excluding the impact of non-cash goodwill impairment.

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

The Company’s reconciliations are included in this release or can be found in the supplemental materials furnished as Exhibit 99.2 to the Company’s Form 8-K dated February 21, 2024.

In evaluating its business, the Company considers and uses Free Cash Flow and Net Debt as supplemental measures of its liquidity and the other non-GAAP financial measures as supplemental measures of its operating performance. Management provides such non-GAAP financial measures so that investors will have the same financial information that management uses with the belief that it will assist investors in properly assessing the Company's performance on a period-over-period basis by excluding matters not indicative of the Company’s ongoing operating or liquidity results and therefore enhance the comparability of the Company's results and provide additional information for analyzing trends in the business. In evaluating our non-GAAP financial measures, you should be aware that in the future we may incur revenues, expenses, and cash and non-cash obligations that are the same as or similar to some of the adjustments in our presentation of non-GAAP financial measures. Our presentation of non-GAAP financial measures should not be construed as an inference that our future results will be unaffected by unusual or non-recurring items. There also can be no assurance that we will not modify the presentation of our non-GAAP financial measures in the future, and any such modification may be material. Other companies in our industry may define and calculate these non-GAAP financial measures differently than we do and those calculations may not be comparable to our metrics. These non-GAAP measures have limitations as analytical tools, and when assessing the Company's operating performance or liquidity, investors should not consider these non-GAAP measures in isolation, or as a substitute for net income, revenue or other consolidated income statement or cash flow statement data prepared in accordance with GAAP.

Non-GAAP measures referenced in this release and other public communications may include estimates of future Adjusted EBITDA, Adjusted EBITDA margin and Adjusted EPS. The Company has not reconciled the non-GAAP forward-looking guidance included in this release to the most directly comparable GAAP measures because this cannot be done without unreasonable effort due to the variability and low visibility with respect to taxes and non-recurring items, which are potential adjustments to future earnings. We expect the variability of these items to have a potentially unpredictable, and a potentially significant, impact on our future GAAP financial results.

 

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

GENTHERM INCORPORATED

ADJUSTED NET INCOME AND ADJUSTED EARNINGS PER SHARE

(In thousands, except per share data)

(Unaudited)

 

 

 

 

Three Months Ended
December 31,

 

 

Year Ended
December 31,

 

 

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Net income (loss)

 

$

18,087

 

 

$

(4,205

)

 

$

40,343

 

 

$

24,441

 

Non-cash purchase accounting impact

 

 

1,604

 

 

 

3,369

 

 

 

7,397

 

 

 

9,795

 

Restructuring expenses

 

 

1,327

 

 

 

76

 

 

 

4,739

 

 

 

637

 

Unrealized currency loss

 

 

4,898

 

 

 

5,678

 

 

 

9,125

 

 

 

4,646

 

Acquisition and integration expenses

 

 

578

 

 

 

4,261

 

 

 

5,308

 

 

 

22,618

 

Impairment of goodwill

 

 

 

 

 

 

 

 

19,509

 

 

 

 

Non-automotive electronics inventory charge

 

 

575

 

 

 

 

 

 

6,064

 

 

 

 

Impairment of intangible assets and property and equipment

 

 

 

 

 

15,669

 

 

 

 

 

 

15,669

 

Other (a)

 

 

4,001

 

 

 

(32

)

 

 

4,072

 

 

 

(515

)

Tax effect of above

 

 

(2,179

)

 

 

(9,185

)

 

 

(10,814

)

 

 

(16,205

)

Adjusted net income

 

$

28,891

 

 

$

15,631

 

 

$

85,743

 

 

$

61,086

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average shares outstanding (in thousands):

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

31,974

 

 

 

33,186

 

 

 

32,778

 

 

 

33,126

 

Diluted

 

 

32,200

 

 

 

33,186

 

 

 

33,067

 

 

 

33,503

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings (loss) per share, as reported:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.57

 

 

$

(0.13

)

 

$

1.23

 

 

$

0.74

 

Diluted

 

$

0.56

 

 

$

(0.13

)

 

$

1.22

 

 

$

0.73

 

Adjusted earnings per share:

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

$

0.90

 

 

$

0.47

 

 

$

2.62

 

 

$

1.84

 

Diluted

 

$

0.90

 

 

$

0.47

 

 

$

2.59

 

 

$

1.82

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(a) Includes $2,900 of non-cash impairment charges related to our Carrar Ltd. Investment for the three and twelve months ended December 31, 2023.

 

 

 

 

 

 

 

 

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

GENTHERM INCORPORATED

CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

 

 

 

December 31,

 

 

 

2023

 

 

2022

 

ASSETS

 

 

 

 

 

 

Current Assets:

 

 

 

 

 

 

Cash and cash equivalents

 

$

149,673

 

 

$

153,891

 

Accounts receivable, net

 

 

253,579

 

 

 

247,131

 

Inventory, net

 

 

205,892

 

 

 

218,248

 

Other current assets

 

 

78,420

 

 

 

64,597

 

Total current assets

 

 

687,564

 

 

 

683,867

 

Property and equipment, net

 

 

245,234

 

 

 

244,480

 

Goodwill

 

 

104,073

 

 

 

119,774

 

Other intangible assets, net

 

 

66,482

 

 

 

73,933

 

Operating lease right-of-use assets

 

 

27,358

 

 

 

29,945

 

Deferred income tax assets

 

 

81,930

 

 

 

69,840

 

Other non-current assets

 

 

21,730

 

 

 

17,461

 

Total assets

 

$

1,234,371

 

 

$

1,239,300

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

 

Accounts payable

 

$

215,827

 

 

$

182,225

 

Current lease liabilities

 

 

7,700

 

 

 

7,143

 

Current maturities of long-term debt

 

 

621

 

 

 

2,443

 

Other current liabilities

 

 

100,805

 

 

 

93,814

 

Total current liabilities

 

 

324,953

 

 

 

285,625

 

Long-term debt, less current maturities

 

 

222,217

 

 

 

232,653

 

Non-current lease liabilities

 

 

16,175

 

 

 

20,538

 

Pension benefit obligation

 

 

3,209

 

 

 

3,638

 

Other non-current liabilities

 

 

23,095

 

 

 

24,573

 

Total liabilities

 

$

589,649

 

 

$

567,027

 

Shareholders’ equity:

 

 

 

 

 

 

Common Stock:

 

 

 

 

 

 

No par value; 55,000,000 shares authorized 31,542,001 and 33,202,082 issued and outstanding at December 31, 2023 and December 31, 2022, respectively

 

 

50,503

 

 

 

122,658

 

Paid-in capital

 

 

 

 

 

5,447

 

Accumulated other comprehensive loss

 

 

(30,160

)

 

 

(46,489

)

Accumulated earnings

 

 

624,379

 

 

 

590,657

 

Total shareholders’ equity

 

 

644,722

 

 

 

672,273

 

Total liabilities and shareholders’ equity

 

$

1,234,371

 

 

$

1,239,300

 

 

 


 

https://cdn.kscope.io/37dcdd115daf55fbf9741750694e6e15-img17760854_0.jpg 

 

GENTHERM INCORPORATED

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

Operating Activities:

 

 

 

 

 

 

Net income

 

$

40,343

 

 

$

24,441

 

Adjustments to reconcile net income to net cash provided by operating activities:

 

 

 

 

 

 

Depreciation and amortization

 

 

50,948

 

 

 

44,394

 

Deferred income taxes

 

 

(13,072

)

 

 

(7,322

)

Stock based compensation

 

 

11,627

 

 

 

6,599

 

Loss on disposition of property and equipment

 

 

721

 

 

 

771

 

Impairment of intangible assets and property and equipment

 

 

 

 

 

6,291

 

Impairment of goodwill

 

 

19,509

 

 

 

 

Provisions for inventory

 

 

6,867

 

 

 

15,923

 

Other

 

 

2,920

 

 

 

721

 

Changes in assets and liabilities:

 

 

 

 

 

 

Accounts receivable, net

 

 

(4,195

)

 

 

(44,221

)

Inventory

 

 

6,907

 

 

 

(40,322

)

Other assets

 

 

(26,179

)

 

 

(11,906

)

Accounts payable

 

 

31,029

 

 

 

28,314

 

Other liabilities

 

 

(8,160

)

 

 

(8,736

)

Net cash provided by operating activities

 

 

119,265

 

 

 

14,947

 

Investing Activities:

 

 

 

 

 

 

Purchases of property and equipment

 

 

(37,602

)

 

 

(39,703

)

Proceeds from the sale of property and equipment

 

 

391

 

 

 

248

 

Acquisition of businesses, net of cash acquired

 

 

 

 

 

(205,487

)

Proceeds from deferred purchase price of factored receivables

 

 

13,903

 

 

 

5,538

 

Cost of technology investments

 

 

(815

)

 

 

(495

)

Net cash used in investing activities

 

 

(24,123

)

 

 

(239,899

)

Financing Activities:

 

 

 

 

 

 

Borrowings on debt

 

 

60,000

 

 

 

207,000

 

Repayments of debt

 

 

(72,280

)

 

 

(13,272

)

Proceeds from the exercise of Common Stock options

 

 

263

 

 

 

1,670

 

Taxes withheld and paid on employee's share-based payment awards

 

 

(2,940

)

 

 

(5,471

)

Cash paid for the repurchase of Common Stock

 

 

(91,094

)

 

 

 

Net cash (used in) provided by financing activities

 

 

(106,051

)

 

 

189,927

 

Foreign currency effect

 

 

6,691

 

 

 

(1,690

)

Net decrease in cash and cash equivalents

 

 

(4,218

)

 

 

(36,715

)

Cash and cash equivalents at beginning of period

 

 

153,891

 

 

 

190,606

 

Cash and cash equivalents at end of period

 

$

149,673

 

 

$

153,891

 

Supplemental disclosure of cash flow information:

 

 

 

 

 

 

Cash paid for taxes

 

$

23,273

 

 

$

21,645

 

Cash paid for interest

 

$

13,242

 

 

$

6,338

 

 

 

 

 

 

 


Slide 1

Proprietary © Gentherm 2024 2023 Fourth Quarter Results & Full Year Results February 21, 2024 Exhibit 99.2


Slide 2

Use of Non-GAAP Financial Measures* In addition to the results reported herein in accordance with GAAP, the Company has provided here or may discuss on the related conference call Adjusted Operating Expense, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted EPS, Free Cash Flow, Net Debt, organic revenue, revenue excluding acquired businesses and foreign currency translation, revenue excluding foreign currency translation, Automotive revenue excluding the impact from the United Auto Workers strike, non-automotive electronics, one-time customer recoveries and foreign currency translation, organic Automotive revenue excluding the impact from the United Auto Workers strike, non-automotive electronics, one-time customer recoveries and foreign currency translation, pro forma product revenues, pro forma Adjusted EBITDA, pro forma Adjusted EBITDA margin and Adjusted Effective Tax Rate, each a non-GAAP financial measure. Starting in 2023, the Company is excluding the impact of non-cash stock-based compensation from its definition of Adjusted EBITDA and Adjusted EBITDA margin. References to Adjusted EBITDA and Adjusted EBITDA margin for prior periods have been recast to exclude the impact of non-cash stock-based compensation. See the Company’s earnings release dated February 21, 2024, for the definitions of each non-GAAP financial measure, information regarding why the Company utilizes such non-GAAP measures as supplemental measures of performance or liquidity, and their limitations, and for certain reconciliations of GAAP to non-GAAP historical financial measures. * See Appendix for certain reconciliations of GAAP to non-GAAP historical financial measures. Proprietary © Gentherm 2024


Slide 3

Forward-Looking Statement Proprietary © Gentherm 2024 Except for historical information contained herein, statements in this presentation are forward-looking statements that are made by Gentherm Incorporated (the “Company”) pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All statements that address future operating, financial or business performance or strategies or expectations are forward-looking statements. The forward-looking statements included in this presentation are made as of the date specified herein and are based on management's reasonable expectations and beliefs. In making these statements we rely on assumptions and analysis based on our experience and perception of historical trends, current conditions and expected future developments, as well as other factors we consider appropriate under the circumstances. Except as required by law, the Company expressly disclaims any obligation or undertaking to update any forward-looking statements to reflect any change in its strategies or expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. The forward-looking statements are subject to a number of important assumptions, risks, uncertainties and other factors that may cause actual results or performance to differ materially from that expressed or implied by such statements. For a discussion of these risks and uncertainties and other factors, please see the Company’s most recent Annual Report on Form 10-K and subsequent filings with the Securities and Exchange Commission, including “Risk Factors.” In addition, the business outlook discussed in this presentation does not include the potential impact of any business combinations, acquisitions, divestitures, strategic investments and other significant transactions that may be completed after the date hereof, each of which may present material risks to the Company’s future business and financial results.


Slide 4

2023 Highlights Proprietary © Gentherm 2024 4 Strong execution led to record results despite challenging environment Generated $120M of cash flow from operations and repurchased $90M of shares Record company Adjusted EBITDA Record $2.6B in Automotive new business awards ​ Record company revenue


Slide 5

Proprietary © Gentherm 2024 Independent partnership model leading to record wins and deeper customer relationships Winning at Record Pace CCS® expanding globally, including fast growing domestic Chinese OEMs; significant growth in hands-on-detection enabled steering wheel heaters Won conquest pneumatic lumbar and massage awards with 8 OEMs globally leveraging the Alfmeier acquisition Won customer programs with combined thermal and pneumatic lumbar / massage solutions Leveraging ClimateSense® and WellSenseTM to increase vehicle content, demonstrated by new business wins Expanding core thermal Growing market share in pneumatic Leading supplier of combined systems Increasing vehicle content ClimateSense® software enabling software defined vehicles Differentiating with software


Slide 6

Proprietary © Gentherm 2024 Industry Leading Innovations Increasing content per vehicle with differentiated and proprietary solutions; well positioned to capitalize on the software defined vehicles of the future ClimateSense® ComfortScale™ Combines thermal, lumbar and massage Proprietary software driven wellness and alertness features Enabling software defined vehicles Best-in-class software controlled thermal comfort Enhances energy efficiency and vehicle range Personalized microclimate Modular and scalable hardware Easy to integrate across OEMs and Tier 1s Enhanced cost efficiency WellSense™


Slide 7

Automotive Highlights Record Automotive revenues in 2023 including record annual revenues for Climate Control Seat (CCS®), Seat Heaters and Steering Wheel Heaters 21 Vehicle launches with 13 OEMs Multiple CCS® Launches  Toyota Tacoma Ford Ranger Mazda CX-90 BEV Truck with large EV Manufacturer Proprietary © Gentherm 2024 7 ClimateSense® named a finalist for the 2023 Automotive News PACE Award


Slide 8

New Automotive Business Awards $900M in awards in 4Q Proprietary © Gentherm 2024 8 Breakthrough scalable ClimateSense® software award with General Motors Steering Wheel Heater awards across 7 OEMs including hands-on-detection enabled heater award with BMW, Geely, General Motors, Li Auto and Nissan 8 Record quarterly and annual Automotive Business Awards driven by accelerating demand for thermal comfort, massage and lumbar solutions Multiple CCS® Awards from: General Motors | Great Wall | HKMC | Nissan | Rivian CCS® and multifunction electronic control unit awards for General Motors’ next generation truck platform Paused pursuit of BPS Cell Connecting


Slide 9

Medical Highlights Double digit revenue growth leveraging large partnerships, distribution and white label opportunities Proprietary © Gentherm 2024 9 Proprietary © Gentherm 2024 9 26 New major hospital account expansion in China Awarded Blanketrol ® lll system upgrades throughout Health Trust Performance Group member hospitals 15% Strong revenue growth as a result of higher Blanketrol® sales


Slide 10

(Dollars in thousands,  except per share data) 2023 2022 2023 2022 Pro forma 2022 (1) Product Revenues $ 366,933 $ 343,322 $ 1,469,076 $ 1,204,656 $ 1,348,295   Automotive 353,945 332,046 1,422,952 1,161,616 1,305,255   Medical 12,988 11,276 46,124 43,040 Gross Margin 96,296 69,808 351,624 273,650 Gross Margin % 26.2 % 20.3 % 23.9 % 22.7 % Operating Expenses 64,593 66,248 274,185 225,343 Operating Income 31,703 3,560 77,439 48,307 Adjusted EBITDA 49,022 40,949 180,584 137,162 139,727 Adjusted EBITDA Margin 13.4 % 11.9 % 12.3 % 11.4 % 10.4 % Diluted EPS - As Adjusted $ 0.90 $ 0.47 $ 2.59 $ 1.82 Select Income Statement Data Twelve Months Ended December 31 Three Months Ended December 31 (1) Pro forma amounts include the results of Alfmeier as if the acquisition had occurred as of January 1, 2022. Proprietary © Gentherm 2024 10


Slide 11

Select Balance Sheet Data December 31, 2023 June 30, 2023 December 31, 2022 December 31, 2022 December 31, 2022 Cash and Cash Equivalents $ 149,673 $ 153,891 Total Assets  1,234,371 1,239,300 Debt 222,838 235,096    Current 621 2,443    Non-Current 222,217 232,653 Revolving LOC Availability 278,000 264,904 Total Liquidity 427,673 418,795 Proprietary © Gentherm 2024 11 (Dollars in thousands)


Slide 12

Proprietary © Gentherm 2024 12 2024 Guidance and 2026 Outlook 2024 E 2026 E Product Revenue (1)(2) $1.5B – $1.6B $1.9B – $2.0B Adjusted EBITDA Margin (1)(2) 12.5% – 13.5% ~ 16% Adjusted Effective Tax Rate 26% – 29% Capital Expenditures $65M – $75M Based on the current forecast of customer orders and light vehicle production in the Company’s key markets declining at a low single-digit rate in 2024 versus 2023. Assumes a EUR to USD exchange rate of $1.10/Euro. Due to the inherent difficulty of forecasting the timing and amount of certain items that would impact net income margin, such as foreign currency gains and losses, we are unable to reasonably estimate net income margin, the GAAP financial measure most directly comparable to Adjusted EBITDA margin. Accordingly, we are unable to provide a reconciliation of Adjusted EBITDA margin to net income margin with respect to the guidance provided.


Slide 13

2024 Priorities Proprietary © Gentherm 2024 13 Laser focused on key priorities to drive operational execution, profitability improvement and innovation ​Execute on Fit-for-Growth 2.0 initiatives to expand margin Deliver industry leading proprietary innovations such as ClimateSense®, WellSenseTM and ComfortScaleTM 03 Lead the industry with new Automotive Business Awards and execute on unprecedented award backlog​


Slide 14

Why Gentherm Poised for high-return growth and outpacing the market 02 Global automotive market is large with rapidly growing penetration of thermal and pneumatic solutions​ 01 Pure play leader in thermal management and pneumatic comfort​ 03 Unique, innovative, energy efficient and software driven solutions key to vehicles of the future​ Consistent execution against strategic plan​ with financial discipline ​ Proprietary © Gentherm 2024


Slide 15

Appendix Proprietary © Gentherm 2024


Slide 16

Proprietary © Gentherm 2024 16 Reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin (Dollars in thousands) 2023 2022 2023 2022 Net Income (Loss) $ 18,087 $ (4,205) $ 40,343 $ 24,441 Add Back:      Income Tax (Benefit) Expense (867) (57) 14,611 13,941      Interest Expense, net 5,197 3,009 14,641 4,294      Depreciation and Amortization  12,062 13,779 50,416 44,038 Adjustments:      Restructuring Expenses  1,327 76 4,739 637      Unrealized Currency Loss  4,898 5,678 9,125 4,646      Acquisition and Integration Expenses 578 4,261 5,308 22,618      Non-Automotive Electronics Inventory Charge 575 – 6,064 –      Impairment of Goodwill – – 19,509 –      Impairment of Intangible Assets and Property and Equipment – 15,669 – 15,669      Non-Cash Stock-Based Compensation 3,164 2,771 11,756 7,393      Other 4,001 (32) 4,072 (515) Adjusted EBITDA  49,022 40,949 180,584 137,162 Product Revenues 366,933 343,322 1,469,076 1,204,656 Net Income Margin 4.9 % (1.2) % 2.7 % 2.0 % Adjusted EBITDA Margin 13.4 % 11.9 % 12.3 % 11.4 % Twelve Months Ended December 31 Three Months Ended December 31


Slide 17

Proprietary © Gentherm 2024 17 Reconciliation of Adjusted EPS 2023 2022 2023 2022 Diluted EPS - As Reported $ 0.56 $ (0.13) $ 1.22 $ 0.73 Acquisition and Integration Expenses 0.02 0.13 0.16 0.68 Non-Cash Purchase Accounting Impacts 0.05 0.10 0.22 0.29 Unrealized Currency Loss 0.15 0.17 0.28 0.14 Restructuring Expenses 0.04 0.00 0.14 0.02 Non-Automotive Electronics Inventory Charge 0.02 – 0.18 – Impairment of Goodwill – – 0.59 – Impairment of Intangible Assets and Property and Equipment – 0.47 – 0.47 Other 0.12 (0.00) 0.12 (0.02) Tax Effect of Above (0.07) (0.28) (0.33) (0.48) Rounding 0.01 0.01 0.01 (0.01) Diluted EPS - As Adjusted 0.90 0.47 2.59 1.82 Three Months Ended December 31 Twelve Months Ended December 31